2:30 Introduction and Overview

2:40-3:15 Changing Market Dynamics Impacting Health Care Economy

• Payer expectations: Commercial and government
• Drug and device coverage changes following Medicare Modernization Act
• Consumer expectations [generics, importation]
• Commercialization implications
• Reimbursement Roadmap™

3:15-3:45 Coding, Coverage and Payment

• Coding new technology
• Local and national coverage decisions
• Practice settings
• Pricing and payment
• Case studies

3:45-4:15 Use of Health Economics Information – Implications for Coverage and Payment

• Increasing demand for health economic analysis
• Use of economic evidence by health care decision makers to support reimbursement and pricing of new biologicals and pharmaceuticals
• Implications for the biotechnology, device, and pharmaceutical industries
• Evidence requirements and methods of health economics
• Managing economics and outcomes research projects
• Case studies

4:15-4:45 Meeting investors’ requirements for economics and outcomes research

• Strategic use of economics and outcomes research findings
• Trends and implications of outcomes research in the R&D process
• Assessing reimbursement likelihood- risk stratification
• Case studies

4:45-5:30 Reimbursement Roadmap™

• Developing an effective reimbursement strategy
• Operational issues around attaining appropriate reimbursement
• Implementation and timelines
• Resource allocation requirements

5:30 Closing remarks